| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.009 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.009 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.074 | 0.01 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | -0.43 | 0.01 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.098 | 0.01 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |